{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T10:00:06Z","timestamp":1789293606609,"version":"build-2803163510"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701239"],"award-info":[{"award-number":["81701239"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771363"],"award-info":[{"award-number":["81771363"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin City","doi-asserted-by":"publisher","award":["18JCQNJC81700"],"award-info":[{"award-number":["18JCQNJC81700"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2020.589928","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T08:27:34Z","timestamp":1605169654000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Increased Cerebrospinal Fluid Uric Acid Levels in Guillain\u2013Barr\u00e9 Syndrome"],"prefix":"10.3389","volume":"11","author":[{"given":"Sheng-Hui","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Bing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Na","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Li","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Sha","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"6858","DOI":"10.1073\/pnas.78.11.6858","article-title":"Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis","volume":"78","author":"Ames","year":"1981","journal-title":"Proc Natl Acad Sci USA."},{"key":"B2","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1080\/15257770802138558","article-title":"Uric acid: the oxidant-antioxidant paradox","volume":"27","author":"Sautin","year":"2008","journal-title":"Nucleosides Nucleotides Nucleic Acids."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1073\/pnas.94.6.2528","article-title":"Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis","volume":"94","author":"Hooper","year":"1997","journal-title":"Proc Natl Acad Sci USA."},{"key":"B4","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/(SICI)1097-4547(19980901)53:5<613::AID-JNR11>3.0.CO;2-1","article-title":"Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo","volume":"53","author":"Yu","year":"1998","journal-title":"J Neurosci Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/0006-8993(89)90786-5","article-title":"Allopurinol inhibits uric acid accumulation in the rat brain following focal cerebral ischemia","volume":"499","author":"Kanemitsu","year":"1989","journal-title":"Brain Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.neurobiolaging.2018.10.031","article-title":"Uric acid enhances longevity and endurance and protects the brain against ischemia","volume":"75","author":"Cutler","year":"2019","journal-title":"Neurobiol Aging."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.1073\/pnas.0500307102","article-title":"Uric acid protects against secondary damage after spinal cord injury","volume":"102","author":"Scott","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"key":"B8","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1179\/016164106X98215","article-title":"Uric acid in multiple sclerosis","volume":"28","author":"Koch","year":"2006","journal-title":"Neurol Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1468-1331.2011.03488.x","article-title":"Low antioxidant status of serum uric acid, bilirubin and albumin in patients with neuromyelitis optica","volume":"19","author":"Peng","year":"2012","journal-title":"Eur J Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.3233\/JAD-2010-1330","article-title":"Uric acid as a CNS antioxidant","volume":"19","author":"Bowman","year":"2010","journal-title":"J Alzheimers Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1001\/jamaneurol.2013.5528","article-title":"Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial","volume":"71","author":"Schwarzschild","year":"2014","journal-title":"JAMA Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.107.129031","article-title":"Altered uric acid levels and disease states","volume":"324","author":"Kutzing","year":"2008","journal-title":"J Pharmacol Exp Ther."},{"key":"B13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1600-0404.2012.01643.x","article-title":"Reduced serum uric acid levels in neuromyelitis optica: serum uric acid levels are reduced during relapses in NMO","volume":"126","author":"Min","year":"2012","journal-title":"Acta Neurol Scand."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.2174\/1568026615666150610143234","article-title":"The role of uric acid and methyl derivatives in the prevention of age-related neurodegenerative disorders","volume":"15","author":"Cutler","year":"2015","journal-title":"Curr Top Med Chem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.clinbiochem.2009.03.020","article-title":"Increase of uric acid and purine compounds in biological fluids of multiple sclerosis patients","volume":"42","author":"Amorini","year":"2009","journal-title":"Clin Biochem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e00584","DOI":"10.1002\/brb3.584","article-title":"Elevated cerebrospinal fluid uric acid during relapse of neuromyelitis optica spectrum disorders","volume":"7","author":"Shu","year":"2017","journal-title":"Brain Behav."},{"key":"B17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0304-3940(97)00840-9","article-title":"Cerebrospinal fluid hypoxanthine, xanthine and uric acid levels may reflect glutamate-mediated excitotoxicity in different neurological diseases","volume":"238","author":"Stover","year":"1997","journal-title":"Neurosci Lett."},{"key":"B18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.autrev.2016.09.022","article-title":"Guillain-Barr\u00e9 syndrome","volume":"16","author":"Esposito","year":"2017","journal-title":"Autoimmun Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.mayocp.2016.12.002","article-title":"Guillain-Barr\u00e9 syndrome","volume":"92","author":"Wijdicks","year":"2017","journal-title":"Mayo Clin Proc."},{"key":"B21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.cccn.2004.03.032","article-title":"Free radical toxicity and antioxidants in guillain-barre syndrome, a preliminary study","volume":"346","author":"Kumar","year":"2004","journal-title":"Clin Chim Acta."},{"key":"B22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3109\/00207451003695690","article-title":"Serum and cerebrospinal fluid antioxidant activity and lipid peroxidation in guillain-barre syndrome and multiple sclerosis patients","volume":"120","author":"Ghabaee","year":"2010","journal-title":"Int J Neurosci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.cca.2017.05.001","article-title":"Alterations of plasma concentrations of lipophilic antioxidants are associated with guillain-barre syndrome","volume":"470","author":"Tang","year":"2017","journal-title":"Clin Chim Acta."},{"key":"B24","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/01616412.2019.1573955","article-title":"Dynamic thiol-disulphide homeostasis in patients with guillain-barre syndrome","volume":"41","author":"G\u00fcm\u00fc\u015fyayla","year":"2019","journal-title":"Neurol Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1177\/1352458507082143","article-title":"Serum uric acid levels of patients with multiple sclerosis and other neurological diseases","volume":"14","author":"Peng","year":"2008","journal-title":"Mult Scler."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e6618","DOI":"10.1097\/MD.0000000000006618","article-title":"Low serum levels of uric acid and albumin in patients with guillain-barre syndrome","volume":"96","author":"Su","year":"2017","journal-title":"Medicine."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1081\/NCN-200027469","article-title":"Urate oxidation in CSF and blood of patients with inflammatory disorders of the nervous system","volume":"23","author":"Becker","year":"2004","journal-title":"Nucleosides Nucleotides Nucleic Acids."},{"key":"B28","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain-Barr\u00e9 syndrome and fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"Sejvar","year":"2011","journal-title":"Vaccine."},{"key":"B29","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/brain\/118.3.597","article-title":"Guillain-Barr\u00e9 syndrome in northern China. relationship to campylobacter jejuni infection and anti-glycolipid antibodies","volume":"118","author":"Ho","year":"1995","journal-title":"Brain."},{"key":"B30","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/rheumatology\/kew293","article-title":"Drug-induced hyperuricaemia and gout","volume":"56","author":"Ben Salem","year":"2017","journal-title":"Rheumatology."},{"key":"B31","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","article-title":"Controlled trial prednisolone in acute polyneuropathy","volume":"2","author":"Hughes","year":"1978","journal-title":"Lancet."},{"key":"B32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1054\/mehy.2000.1118","article-title":"The role of uric acid in protection against peroxynitrite-mediated pathology","volume":"56","author":"Scott","year":"2001","journal-title":"Med Hypotheses."},{"key":"B33","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1212\/WNL.58.2.186","article-title":"Oxidative stress in bacterial meningitis in humans","volume":"58","author":"Kastenbauer","year":"2002","journal-title":"Neurology."},{"key":"B34","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/nrd2222","article-title":"Peroxynitrite: biochemistry, pathophysiology and development of therapeutics","volume":"6","author":"Szab\u00f3","year":"2007","journal-title":"Nat Rev Drug Discov."},{"key":"B35","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.bbadis.2015.09.018","article-title":"Oxidative stress and its impact on neurons and glia in multiple sclerosis lesions","volume":"1862","author":"Lassmann","year":"2016","journal-title":"Biochimica Et Biophysica Acta."},{"key":"B36","doi-asserted-by":"publisher","first-page":"708659","DOI":"10.1155\/2013\/708659","article-title":"Immunology and oxidative stress in multiple sclerosis: clinical and basic approach","volume":"2013","author":"Ortiz","year":"2013","journal-title":"Clin Dev Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1073\/pnas.95.2.675","article-title":"Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis","volume":"95","author":"Hooper","year":"1998","journal-title":"Proc Natl Acad Sci USA."},{"key":"B38","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1515\/CCLM.2009.192","article-title":"Cerebrospinal fluid and serum uric acid levels in patients with multiple sclerosis","volume":"47","author":"Dujmovic","year":"2009","journal-title":"Clin Chem Lab Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s00415-005-0697-z","article-title":"No evidence of increased oxidative degradation of urate to allantoin in the CSF and serum of patients with multiple sclerosis","volume":"252","author":"Kastenbauer","year":"2005","journal-title":"J Neurol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.clineuro.2008.03.002","article-title":"Serum and cerebrospinal fluid uric acid levels in multiple sclerosis patients","volume":"110","author":"Zamani","year":"2008","journal-title":"Clin Neurol Neurosurg."},{"key":"B41","doi-asserted-by":"publisher","first-page":"6511","DOI":"10.4049\/jimmunol.165.11.6511","article-title":"The peroxynitrite scavenger uric acid prevents inflammatory cell invasion into the central nervous system in experimental allergic encephalomyelitis through maintenance of blood-central nervous system barrier integrity","volume":"165","author":"Kean","year":"2000","journal-title":"J Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S0891-5849(02)01048-1","article-title":"Comparison of uric acid and ascorbic acid in protection against EAE","volume":"33","author":"Spitsin","year":"2002","journal-title":"Free Radic Biol Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12974-018-1095-7","article-title":"Enhanced glycolysis contributes to the pathogenesis of experimental autoimmune neuritis","volume":"15","author":"Liu","year":"2018","journal-title":"J Neuroinflammation."},{"key":"B44","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12974-016-0502-1","article-title":"Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression","volume":"13","author":"Albanese","year":"2016","journal-title":"J Neuroinflammation."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e025348","DOI":"10.1136\/bmjopen-2018-025348","article-title":"Causes of albuminocytological dissociation and the impact of age-adjusted cerebrospinal fluid protein reference intervals: a retrospective chart review of 2627 samples collected at tertiary care centre","volume":"9","author":"Brooks","year":"2019","journal-title":"BMJ Open."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s00415-010-5455-1","article-title":"Serum uric acid levels and neuromyelitis optica","volume":"257","author":"Peng","year":"2010","journal-title":"J Neurol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1210\/jc.2007-2467","article-title":"Effect of long-term administration of cross-sex hormone therapy on serum and urinary uric acid in transsexual persons","volume":"93","author":"Yahyaoui","year":"2008","journal-title":"J Clin Endocrinol Metabol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1136\/jnnp-2012-302824","article-title":"Bickerstaff brainstem encephalitis and fisher syndrome: anti-GQ1b antibody syndrome","volume":"84","author":"Shahrizaila","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B49","doi-asserted-by":"publisher","first-page":"360438","DOI":"10.1155\/2014\/360438","article-title":"Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal","volume":"2014","author":"Ayala","year":"2014","journal-title":"Oxid Med Cell Longev."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2020.589928\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T08:27:36Z","timestamp":1605169656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2020.589928\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,12]]},"references-count":49,"alternative-id":["10.3389\/fneur.2020.589928"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2020.589928","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,12]]},"article-number":"589928"}}